Sun Pharma Advanced Research Co P/E Ratio
Current P/E Ratio
4.39
Low Valuation
Very Low - Potentially undervalued or facing challenges
Sun Pharma Advanced Research Co (SPARC) P/E ratio is 4.39 (Low), EPS (TTM) ₹47.86, current price ₹221.35 on NSE — Very Low - Potentially undervalued or facing challenges. Analyse SPARC shareholding pattern to track promoter, FII and institutional holdings.
Current Valuation Metrics
P/E Ratio
4.39
Current Price
₹221.35
EPS (TTM)
₹47.86
Exchange
NSE
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
49.28
Sector Median
29.34
Sector Rank
#4 of 193
Sector Percentile
2.1%
Earnings Breakdown (TTM)
TTM EPS
₹48.49
Mar 2026
₹54.27
Sept 2025
₹-2.34
SPARC P/E Ratio — Valuation Signal & Historical Context
Sun Pharma Advanced Research Co P/E 4.39 — signal: Undervalued. For live price, revenue and the complete fundamental profile, see SPARC share price screener.
- Stock appears undervalued with PE of 4.39, suggesting potential buying opportunity
- Trading at discount to sector average PE of 49.28
SPARC vs Healthcare Peers — P/E Ratio Comparison
Sun Pharma Advanced Research Co P/E 4.39 vs Healthcare average 49.28, median 29.34 — range 0.97–869.57.
Sector Average
49.28
Sector Median
29.34
Lowest P/E
0.97
Highest P/E
869.57
Companies
193
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.13 | ₹53 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.61 | ₹1,146 | Low |
| Amwill Health Care | AMWILL | 6.04 | ₹65 | Low |
| Mono Pharmacare | MONOPHARMA | 6.85 | ₹20 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹28 | Low |
| Brooks Laboratories | BROOKS | 7.38 | ₹166 | Low |
| Shelter Pharma | SHELTER | 7.4 | ₹54 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹79 | Low |